NASDAQ$THRD

Third Harmonic Bio Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.82

No prior period
Net Income

-$3.22M

No prior period
Operating Income

-$3.78M

No prior period
Gross Profit

$0.00

No prior period
R&D Expense

$3.27M

No prior period

Revenue & EPS history

Third Harmonic · Revenue · Quarterly

$0

Q1 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 5 quarterly earnings reports

Historical avg

+1.0%

Avg return

Earnings day

+14.2%

Avg return

5 days after

+13.0%

Avg return

30 days after

40%

6 / 15 earnings

Positive

+13.0%

Q3 2024

Best reaction

-11.1%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2025+0.6%-0.2%+5.8%
Q4 2024-1.1%+42.1%+41.9%
Q3 2024+13.0%+13.0%-11.2%
Q2 2024+10.6%+11.5%+9.2%
Q1 2024+10.2%+11.8%+3.3%
Q4 2023+8.0%+7.1%+29.2%
Q3 2023+0.8%
Q2 2023-6.4%
Q1 2023-11.1%
Q4 2022-3.5%
Q3 2021-1.2%
Q4 2021-1.2%
Q3 2022-1.2%
Q1 2022-1.2%
Q2 2022-1.2%
Q2 2021
Q1 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro